|
 |
![]()
|
< back /
08:30 |
Introduction |
|
|
|
08:35
 |
Incretin Hormones: Relevance to clinical management of diabetes |
Rémi Rabasa-Lhoret, MD |
08:55
|
Advances in Oral Therapy |
Jean-Francois Yale, MD |
09:15
|
Importance of Reaching an LDL Goal |
Morris Schweitzer, MD |
09:35
|
Insulin Delivery - Can we do better? |
Jean-Francois Yale, MD |
09:55 |
Q & A and Panel Discussion |
All Faculty |
10:25 |
BREAK |
|
|
10:45
|
Update on Glycemic Control: Care gap |
Lawrence Leiter, MD |
11:10
|
Can We Stop the Progression of Diabetes: DREAM |
Jean-Francois Yale, MD |
11:35
|
ADOPT: Are all hypoglycemic agents the same? |
Tina Kader, MD |
12:00 |
Q & A and Panel Discussion |
All Faculty |
12:30 |
LUNCH |
|
|
13:15
|
Which patients with diabetes should have a stress test?
Does it make a difference ? |
David Fitchett, MD |
13:35
|
Oral Hypoglycemic Agents and CV risk |
Tina Kader, MD |
13:55
|
New Initiatives From the Canadian Heart Research Centre |
Anatoly Langer, MD |
14:15
|
Cardiovascular Risk Stratification in the Patient with Type 2 Diabetes |
David Fitchett, MD |
14:35 |
Q & A and Panel Discussion |
All Faculty |
15:00 |
CLOSE |
|
|
|
 |
|
